Indication
Relapsing form of multiple sclerosis
Relapsing forms of multiple sclerosis represent a category of chronic autoimmune disorders affecting the central nervous system, predominantly diagnosed in young to middle-aged adults with a female predominance. Read more about Relapsing form of multiple sclerosis
125 drugs 54 manufacturers
Drugs that treat it
Common Relapsing form of multiple sclerosis therapies.
KESIMPTA PEN (ofatumumab)
ZEPOSIA (ozanimod hydrochloride)
ZEPOSIA STARTER PACK (ozanimod hydrochloride)
ZEPOSIA STARTER KIT (ozanimod hydrochloride)
PONVORY (ponesimod)
PONVORY 14-DAY STARTER PACK (ponesimod)
REBIF (WITH ALBUMIN) (interferon beta-1a/albumin human)
REBIF TITRATION PACK (interferon beta-1a/albumin human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRelapsing forms of multiple sclerosis represent a category of chronic autoimmune disorders affecting the central nervous system, predominantly diagnosed in young to middle-aged adults with a female predominance.
In regulatory and clinical contexts, this indication encompasses clinically isolated syndrome, relapsing-remitting multiple sclerosis, and active secondary progressive multiple sclerosis.
Pathophysiologically, it is driven by intermittent inflammatory attacks that cause demyelination, axonal injury, and gliosis within the brain, optic nerves, and spinal cord.
Clinically, it is characterized by acute episodes of worsening neurological dysfunction, known as relapses or exacerbations, followed by periods of partial or complete symptom recovery without intervening progression.
- nih.gov
Relapsing forms of multiple sclerosis represent a category of chronic autoimmune disorders affecting the central nervous system, predominantly diagnosed in young to middle-aged adults with a female predominance Pathophysiologically, it is driven by intermittent inflammatory attacks that cause demyelination, axonal injury, and gliosis within the brain, optic nerves, and spinal cord
- nih.gov
Relapsing forms of multiple sclerosis represent a category of chronic autoimmune disorders affecting the central nervous system, predominantly diagnosed in young to middle-aged adults with a female predominance Pathophysiologically, it is driven by intermittent inflammatory attacks that cause demyelination, axonal injury, and gliosis within the brain, optic nerves, and spinal cord Clinically, it is characterized by acute episodes of worsening neurological dysfunction, known as relapses or exacer...
- hopkinsmedicine.org
Relapsing forms of multiple sclerosis represent a category of chronic autoimmune disorders affecting the central nervous system, predominantly diagnosed in young to middle-aged adults with a female predominance
- nationalmssociety.org
In regulatory and clinical contexts, this indication encompasses clinically isolated syndrome, relapsing-remitting multiple sclerosis, and active secondary progressive multiple sclerosis
- nih.gov
Pathophysiologically, it is driven by intermittent inflammatory attacks that cause demyelination, axonal injury, and gliosis within the brain, optic nerves, and spinal cord
- nationalmssociety.org
Clinically, it is characterized by acute episodes of worsening neurological dysfunction, known as relapses or exacerbations, followed by periods of partial or complete symptom recovery without intervening progression
Personalize your experience
Follow Relapsing form of multiple sclerosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.